ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Samir S. Shah
Peter Goldstraw
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shah, S. S.
Right arrow Articles by Goldstraw, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shah, S. S.
Right arrow Articles by Goldstraw, P.

Ann Thorac Surg 1992;54:498-501
© 1992 The Society of Thoracic Surgeons

Articles

Results of operation without adjuvant therapy in the treatment of small cell lung cancer

Samir S. Shah, MBBS*, Joao Thompson, MD, Peter Goldstraw, FRCS

Department of Thoracic Surgery, Royal Brompton National Heart & Lung Hospitals, London, England

Accepted for publication February 24, 1992.

* Address reprint requests to Dr Shah, Department of Thoracic Surgery, Royal Brompton National Heart & Lung Hospitals, Sydney St, London SW3 6NP, England.

The role of surgery in the treatment of small cell lung cancer remains a subject of debate. We carried out a retrospective review of 87 patients with small cell lung cancer referred to one surgeon for staging and treatment. Thirty patients (34.5%) were deemed suitable for thoracotomy. Fourteen patients had stage I disease, 5 patients had stage II disease, and 11 patients had stage III disease. Twenty-eight of the 30 patients (93.3%) went on to have surgical resection. The actual overall 5-year survival in all patients who underwent thoracotomy was 43.3%. The actual 5-year survival for patients in stages I and III was 57.1% and 55.5%, respectively. No patients with stage II disease survived 5 years. We conclude that there is a small group of patients with small cell lung cancer in whom, with careful preoperative staging, the prospects of cure by operation are similar to those with non-small lung cancer.




This article has been cited by other articles:


Home page
 Eur J Cardiothorac SurgHome page
A. Granetzny, A. Boseila, W. Wagner, G. Krukemeyer, U. Vogt, E. Hecker, O. M. Koch, and F. Klinke
Surgery in the tri-modality treatment of small cell lung cancer. Stage-dependent survival
Eur J Cardiothorac Surg, August 1, 2006; 30(2): 212 - 216.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. Tsuchiya, K. Suzuki, Y. Ichinose, Y. Watanabe, T. Yasumitsu, N. Ishizuka, and H. Kato
Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101)
J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 977 - 983.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. Kumar, Y. Xiu, J. Q. Yu, A. Takalkar, G. El-Haddad, S. Potenta, J. Kung, H. Zhuang, and A. Alavi
18F-FDG PET in Evaluation of Adrenal Lesions in Patients with Lung Cancer
J. Nucl. Med., December 1, 2004; 45(12): 2058 - 2062.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Compr Canc NetwHome page
R. J. Downey and L. M. Krug
Surgery in the Management of Small Cell Lung Cancer
J Natl Compr Canc Netw, March 1, 2004; 2(2): 159 - 162.
[Abstract] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
T. Lewinski, M. zulawski, C. Turski, and A. Pietraszek
Small cell lung cancer I-III A: cytoreductive chemotherapy followed by resection with continuation of chemotherapy
Eur J Cardiothorac Surg, August 1, 2001; 20(2): 391 - 398.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. J. Ginsberg
Small cell lung cancer: how should we treat it? what is it?
Ann. Thorac. Surg., November 1, 2000; 70(5): 1453 - 1454.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.